Dr Reddy's PAT up 77 per cent at Rs 504 Cr in Q2
Dr Reddys Laboratories Limited Friday said its profit after tax for the quarter ended September 30 was up by 77 per cent to Rs 504 crore against Rs 387.6 crore in the second quarter of FY18.
Revenues from Global Generics segment in the Q2 was reported at Rs 3050 crore a year-on-year growth of 7 per cent over the same quarter last year. Image courtesy: Reuters